Scinai Immunotherapeutics Ltd (SCNI): Qarzning balans kapitallashuviga nisbati
Infeksiyalarga qarshi nanotanalarning ishlab chiqilishi kelajakdagi katalizatorlarni yaratadi, R&D xarajatlari esa allaqachon narxga kiritilgan. Scinai Immunotherapeutics (SCNI) aksiyalari makroiqtisodiy omillardan mustaqil qolmoqda, chunki muvaffaqiyat sinovlarning borishi bilan belgilanadi. Qarzning kapitalga nisbati grafigi risklar dinamikasini tasdiqlaydi, bunda 0.32 parametrning joriy holatini belgilaydi. Innovatsion antitanalar va patent himoyasi Scinai Immunotherapeutics (SCNI) kompaniyasining kasalliklarning oldini olish sohasidagi uzoq muddatli ustunligini ta'minlaydi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_SCNI_-_Scinai-Immunotherapeutics_-_Debt-to-Net-Assets-Ratio "SCNI: Scinai Immunotherapeutics Qarzning balans kapitallashuviga nisbati 21.02.2024 - 30.10.2026 | 👁️GURU.Markets👁️")
Scinai Immunotherapeutics Ltd (SCNI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Scinai Immunotherapeutics|SCNI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Scinai|SCNI - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati BiondVax Pharmaceuticals|SCNI - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Scinai Immunotherapeutics|Tezkor likvidlik ko‘rsatkichi scinai.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:SCNI (Scinai Immunotherapeutics)
Scinai Immunotherapeutics joriy daromadlarsiz, yuqori xavfli tadqiqot va ishlanmalar ( R&D ) sektorida faoliyat yuritadi. Ushbu koeffitsient tashqi majburiyatlar hajmini sof aktivlarga solishtirib, moliyaviy mustaqillik darajasini belgilaydi. Mazkur ko'rsatkich bozor narxi va real fundamental omillar o'rtasidagi tafovutlarni ochib beradi hamda hissiy baholashni bartaraf etadi. Biologik preparatlarga yo'naltirilgan yuqori kapital sarfi ushbu balansni yashab qolish uchun muhim qiladi. Umumiy qarzdorlikning kapitalga nisbati grafigining tahlili sinovlar muvaffaqiyatsiz tugagan taqdirda bankrotlik xavfini baholash imkonini beradi.
Scinai Immunotherapeutics (SCNI) raqobatchilari
Balans kapitallashuviga qarzlar ARGX (argenx SE)|Balans kapitallashuviga qarzlar biontech.de BNTX|ABVX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADMA (ADMA Biologics Inc)|Protagonist Therapeutics Inc (PTGX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com|Qarzning balans qiymatiga nisbati ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AUPH (Aurinia Pharma)|Sof aktivlarga qarzlar BioCryst Corp (BCRX)|VERA - Qarzning balans kapitallashuviga nisbati|dianthustx.com (DNTH) - Qarzning balans qiymatiga nisbati|Pharvaris (PHVS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|Qarzning balans qiymatiga nisbati TRML|Balans kapitallashuviga qarzlar Precigen Corp|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. (PHAR)|nektar.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UPB (Upstream Bio)|Zenas Bio (ZBIO) - Balans qiymatiga qarzlar|IMNM - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Gossamer Bio Corp. GOSS|KALV: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati septerna.com|PVLA (Pieris Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Savara Inc (SVRA) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ATXS (Astria Therapeutics)|Balans kapitallashuviga qarzlar engene.com ENGN|RAPT Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Aerovate Therapeutics Inc JBIO|ACRS (Aclaris) - Qarzning balans qiymatiga nisbati|Kyverna Therapeutics, Inc - Qarzning sof aktivlarga nisbati|TLSA (Tiziana Life Sciences) - Balans kapitallashuviga qarzlar|cabalettabio.com (CABA) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Ventyx Biosciences, Inc. (VTYX)|Qarzning balans qiymatiga nisbati Theratechnologies, Inc. THTX|Qarzning balans kapitallashuviga nisbati Avalo Therapeutics Inc. AVTX|ELDN - Qarzning balans qiymatiga nisbati|AGEN: Qarzning balans qiymatiga nisbati|CLYM - Balans kapitallashuviga qarzlar|Zura Bio Limited (ZURA) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ATYR|Qarzning balans kapitallashuviga nisbati Adagene Inc|Balans qiymatiga qarzlar Ikena Oncology, Inc. IMA|Qarzning balans qiymatiga nisbati STTK (Shattuck Labs, Inc.)|Qarzning balans kapitaliga nisbati EQ|Balans kapitallashuviga qarzlar CNTB (Connect Biopharma Holdings Limited)|Qarzning sof aktivlarga nisbati IMUX|Atara Biotherapeutics Inc - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar InflaRx N.V.|X4 Pharmaceuticals (XFOR) - Qarzning balans kapitallashuviga nisbati|Adicet Bio, Inc. - Qarzning sof aktivlarga nisbati|CELU (Celularity Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar INmune Bio Inc|Qarzning balans kapitallashuviga nisbati Barinthus Bio (BRNS)|KZR: Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar SABS (SAB Biotherapeutics)|akaritx.com (AKTX) - Balans qiymatiga qarzlar|ENLV: Qarzning balans qiymatiga nisbati|QTTB - Balans kapitallashuviga qarzlar|GOVX (GeoVax Labs Inc) - Qarzning balans qiymatiga nisbati|EDSA: Qarzning balans kapitaliga nisbati|IBIO (iBio, Inc.) - Balans kapitallashuviga qarzlar|Carisma Tx (CARM) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar XTLB|Qarzning balans qiymatiga nisbati boltbio.com BOLT|Qarzning balans kapitallashuviga nisbati HCW Biologics HCWB|Sof aktivlarga qarzlar Aptevo Therapeutics, Inc. (APVO)|AIM - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Aditxt ADTX|GRI: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati XORTX Therapeutics Inc|Qarzning balans kapitallashuviga nisbati ReShape Lifesciences|Qarzning balans qiymatiga nisbati REVB (Revelation Biosciences Corp)|Balans kapitallashuviga qarzlar INDP|Sof aktivlarga qarzlar calcimedica.com|Qarzning balans kapitallashuviga nisbati Affimed N.V. AFMD|ALLK (Allakos Inc) - Qarzlarning balans kapitallashuviga nisbati|HOOKIPA - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati IGMS (IGM Biosciences, Inc.)|ITOS: Balans kapitallashuviga qarzlar|oceanbiomedical.com (OCEA) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati TC BioPharm|THRD: Qarzning sof aktivlarga nisbati